IBDEI10T ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16598,0)
;;=D69.59^^61^775^190
;;^UTILITY(U,$J,358.3,16598,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16598,1,3,0)
;;=3^Secondary Thrombocytopenia,Other
;;^UTILITY(U,$J,358.3,16598,1,4,0)
;;=4^D69.59
;;^UTILITY(U,$J,358.3,16598,2)
;;=^5002369
;;^UTILITY(U,$J,358.3,16599,0)
;;=C22.7^^61^775^51
;;^UTILITY(U,$J,358.3,16599,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16599,1,3,0)
;;=3^Carcinomas of Liver,Other Spec
;;^UTILITY(U,$J,358.3,16599,1,4,0)
;;=4^C22.7
;;^UTILITY(U,$J,358.3,16599,2)
;;=^5000938
;;^UTILITY(U,$J,358.3,16600,0)
;;=D75.89^^61^775^61
;;^UTILITY(U,$J,358.3,16600,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16600,1,3,0)
;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
;;^UTILITY(U,$J,358.3,16600,1,4,0)
;;=4^D75.89
;;^UTILITY(U,$J,358.3,16600,2)
;;=^5002392
;;^UTILITY(U,$J,358.3,16601,0)
;;=D47.Z9^^61^775^182
;;^UTILITY(U,$J,358.3,16601,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16601,1,3,0)
;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
;;^UTILITY(U,$J,358.3,16601,1,4,0)
;;=4^D47.Z9
;;^UTILITY(U,$J,358.3,16601,2)
;;=^5002262
;;^UTILITY(U,$J,358.3,16602,0)
;;=D05.82^^61^775^39
;;^UTILITY(U,$J,358.3,16602,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16602,1,3,0)
;;=3^Carcinoma in Situ Left Breast,Other Spec Type
;;^UTILITY(U,$J,358.3,16602,1,4,0)
;;=4^D05.82
;;^UTILITY(U,$J,358.3,16602,2)
;;=^5001934
;;^UTILITY(U,$J,358.3,16603,0)
;;=D05.81^^61^775^41
;;^UTILITY(U,$J,358.3,16603,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16603,1,3,0)
;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
;;^UTILITY(U,$J,358.3,16603,1,4,0)
;;=4^D05.81
;;^UTILITY(U,$J,358.3,16603,2)
;;=^5001933
;;^UTILITY(U,$J,358.3,16604,0)
;;=D05.80^^61^775^43
;;^UTILITY(U,$J,358.3,16604,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16604,1,3,0)
;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
;;^UTILITY(U,$J,358.3,16604,1,4,0)
;;=4^D05.80
;;^UTILITY(U,$J,358.3,16604,2)
;;=^5001932
;;^UTILITY(U,$J,358.3,16605,0)
;;=D56.8^^61^775^205
;;^UTILITY(U,$J,358.3,16605,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16605,1,3,0)
;;=3^Thalassemias,Other
;;^UTILITY(U,$J,358.3,16605,1,4,0)
;;=4^D56.8
;;^UTILITY(U,$J,358.3,16605,2)
;;=^5002305
;;^UTILITY(U,$J,358.3,16606,0)
;;=C82.89^^61^775^81
;;^UTILITY(U,$J,358.3,16606,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16606,1,3,0)
;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
;;^UTILITY(U,$J,358.3,16606,1,4,0)
;;=4^C82.89
;;^UTILITY(U,$J,358.3,16606,2)
;;=^5001540
;;^UTILITY(U,$J,358.3,16607,0)
;;=D51.8^^61^775^212
;;^UTILITY(U,$J,358.3,16607,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16607,1,3,0)
;;=3^Vitamin B12 Deficiency Anemias,Other
;;^UTILITY(U,$J,358.3,16607,1,4,0)
;;=4^D51.8
;;^UTILITY(U,$J,358.3,16607,2)
;;=^5002288
;;^UTILITY(U,$J,358.3,16608,0)
;;=I80.9^^61^775^187
;;^UTILITY(U,$J,358.3,16608,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16608,1,3,0)
;;=3^Phlebitis/Thrombophlebitis,Unspec Site
;;^UTILITY(U,$J,358.3,16608,1,4,0)
;;=4^I80.9
;;^UTILITY(U,$J,358.3,16608,2)
;;=^93357
;;^UTILITY(U,$J,358.3,16609,0)
;;=D45.^^61^775^188
;;^UTILITY(U,$J,358.3,16609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16609,1,3,0)
;;=3^Polycythemia Vera
;;^UTILITY(U,$J,358.3,16609,1,4,0)
;;=4^D45.
;;^UTILITY(U,$J,358.3,16609,2)
;;=^96105
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10T 3765 printed Oct 16, 2024@18:00:21 Page 2
IBDEI10T ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16598,0)
+2 ;;=D69.59^^61^775^190
+3 ;;^UTILITY(U,$J,358.3,16598,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,16598,1,3,0)
+6 ;;=3^Secondary Thrombocytopenia,Other
+7 ;;^UTILITY(U,$J,358.3,16598,1,4,0)
+8 ;;=4^D69.59
+9 ;;^UTILITY(U,$J,358.3,16598,2)
+10 ;;=^5002369
+11 ;;^UTILITY(U,$J,358.3,16599,0)
+12 ;;=C22.7^^61^775^51
+13 ;;^UTILITY(U,$J,358.3,16599,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,16599,1,3,0)
+16 ;;=3^Carcinomas of Liver,Other Spec
+17 ;;^UTILITY(U,$J,358.3,16599,1,4,0)
+18 ;;=4^C22.7
+19 ;;^UTILITY(U,$J,358.3,16599,2)
+20 ;;=^5000938
+21 ;;^UTILITY(U,$J,358.3,16600,0)
+22 ;;=D75.89^^61^775^61
+23 ;;^UTILITY(U,$J,358.3,16600,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,16600,1,3,0)
+26 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
+27 ;;^UTILITY(U,$J,358.3,16600,1,4,0)
+28 ;;=4^D75.89
+29 ;;^UTILITY(U,$J,358.3,16600,2)
+30 ;;=^5002392
+31 ;;^UTILITY(U,$J,358.3,16601,0)
+32 ;;=D47.Z9^^61^775^182
+33 ;;^UTILITY(U,$J,358.3,16601,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,16601,1,3,0)
+36 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
+37 ;;^UTILITY(U,$J,358.3,16601,1,4,0)
+38 ;;=4^D47.Z9
+39 ;;^UTILITY(U,$J,358.3,16601,2)
+40 ;;=^5002262
+41 ;;^UTILITY(U,$J,358.3,16602,0)
+42 ;;=D05.82^^61^775^39
+43 ;;^UTILITY(U,$J,358.3,16602,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,16602,1,3,0)
+46 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
+47 ;;^UTILITY(U,$J,358.3,16602,1,4,0)
+48 ;;=4^D05.82
+49 ;;^UTILITY(U,$J,358.3,16602,2)
+50 ;;=^5001934
+51 ;;^UTILITY(U,$J,358.3,16603,0)
+52 ;;=D05.81^^61^775^41
+53 ;;^UTILITY(U,$J,358.3,16603,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,16603,1,3,0)
+56 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
+57 ;;^UTILITY(U,$J,358.3,16603,1,4,0)
+58 ;;=4^D05.81
+59 ;;^UTILITY(U,$J,358.3,16603,2)
+60 ;;=^5001933
+61 ;;^UTILITY(U,$J,358.3,16604,0)
+62 ;;=D05.80^^61^775^43
+63 ;;^UTILITY(U,$J,358.3,16604,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,16604,1,3,0)
+66 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
+67 ;;^UTILITY(U,$J,358.3,16604,1,4,0)
+68 ;;=4^D05.80
+69 ;;^UTILITY(U,$J,358.3,16604,2)
+70 ;;=^5001932
+71 ;;^UTILITY(U,$J,358.3,16605,0)
+72 ;;=D56.8^^61^775^205
+73 ;;^UTILITY(U,$J,358.3,16605,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,16605,1,3,0)
+76 ;;=3^Thalassemias,Other
+77 ;;^UTILITY(U,$J,358.3,16605,1,4,0)
+78 ;;=4^D56.8
+79 ;;^UTILITY(U,$J,358.3,16605,2)
+80 ;;=^5002305
+81 ;;^UTILITY(U,$J,358.3,16606,0)
+82 ;;=C82.89^^61^775^81
+83 ;;^UTILITY(U,$J,358.3,16606,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,16606,1,3,0)
+86 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
+87 ;;^UTILITY(U,$J,358.3,16606,1,4,0)
+88 ;;=4^C82.89
+89 ;;^UTILITY(U,$J,358.3,16606,2)
+90 ;;=^5001540
+91 ;;^UTILITY(U,$J,358.3,16607,0)
+92 ;;=D51.8^^61^775^212
+93 ;;^UTILITY(U,$J,358.3,16607,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,16607,1,3,0)
+96 ;;=3^Vitamin B12 Deficiency Anemias,Other
+97 ;;^UTILITY(U,$J,358.3,16607,1,4,0)
+98 ;;=4^D51.8
+99 ;;^UTILITY(U,$J,358.3,16607,2)
+100 ;;=^5002288
+101 ;;^UTILITY(U,$J,358.3,16608,0)
+102 ;;=I80.9^^61^775^187
+103 ;;^UTILITY(U,$J,358.3,16608,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,16608,1,3,0)
+106 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
+107 ;;^UTILITY(U,$J,358.3,16608,1,4,0)
+108 ;;=4^I80.9
+109 ;;^UTILITY(U,$J,358.3,16608,2)
+110 ;;=^93357
+111 ;;^UTILITY(U,$J,358.3,16609,0)
+112 ;;=D45.^^61^775^188
+113 ;;^UTILITY(U,$J,358.3,16609,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,16609,1,3,0)
+116 ;;=3^Polycythemia Vera
+117 ;;^UTILITY(U,$J,358.3,16609,1,4,0)
+118 ;;=4^D45.
+119 ;;^UTILITY(U,$J,358.3,16609,2)
+120 ;;=^96105
